Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy
about
PodocytesInvariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosisClinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeMouse models of MYH9-related disease: mutations in nonmuscle myosin II-A.Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis.Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression.Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome.Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathiesGenetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation.Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital imagesPrimary cilia disappear in rat podocytes during glomerular development.Association of preeclampsia with podocyte turnover.The glomerulus--a view from the outside--the podocyte.High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen speciesActivation of NFAT signaling in podocytes causes glomerulosclerosis.Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE)Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathyMessenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathyGlomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathyMechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.Microalbuminuria and early renal response to lethal dose Shiga toxin type 2 in rats.Prorenin receptor is essential for normal podocyte structure and functionThe new era of APOL1-associated glomerulosclerosis.Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS.Circulating suPAR in two cohorts of primary FSGS.High glucose induces autophagy in podocytes.Rituximab in idiopathic nephrotic syndrome: does it make sense?Novel biomarkers in glomerular disease.A conceptual framework for the molecular pathogenesis of progressive kidney disease.Genetics of hereditary nephrotic syndrome: a clinical review.Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptorUnderstanding podocytopathy and its relevance to clinical nephrology.Viruses and collapsing glomerulopathy: a brief critical review.Prospects for Precision Medicine in Glomerulonephritis Treatment.Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.
P2860
Q26766118-CD2877F2-E145-420E-BF59-15D3AA088577Q27308115-7A9BB934-00D3-44AC-8C38-ECB374AB2F07Q30427819-042CF2CD-F2F8-412A-B4CC-8894C62AFA23Q33397121-B3F829D0-A32A-461F-A0BC-348ECF229CC5Q33513803-85B07825-6E9C-47B2-93A4-B12974EA0384Q33588228-A80392C7-A261-4B19-A211-FC6B398E2A97Q33622259-7A5EADA4-EC40-41A3-BB11-7EDC0E1FF62DQ33803050-21B58284-A9B0-4235-96B4-0844C0C1F28BQ33821365-0F97CA02-9F83-42D1-990F-D41930874B3CQ33915270-0651A98A-4D72-4EBD-82C9-93F8E06D45D1Q33967627-845E8EB0-47AB-4962-99C1-32A2B78917D5Q34008986-4D786885-E9D0-4481-9295-88FACF73B902Q34020798-952FAF2F-E2D9-4157-814F-C24FC2B972C3Q34053587-7DD5F77F-E074-4BC7-8779-0366B84B7D79Q34455455-79B43D65-9F3D-4488-AC41-D7FB9BFFF165Q34580772-9B4A8AA1-0128-4886-BC17-8DEF568EA1D8Q34744328-8CED9776-CB84-41CC-A6A2-B2678B1CC3DAQ35011234-9646BFE8-9BA3-4CFE-8EA9-85CAF7738F86Q35057836-CD7AD949-08B4-490F-A418-C008DFAD611EQ35634955-83B6E0CA-B35F-43E4-93F3-18E26D422699Q35649310-79F15E69-397E-4149-A5A7-3CE26F321F54Q35669295-FB590FF9-EA99-472F-BB21-36FECE3663A4Q35753161-680E4D73-F2C4-416B-BCF6-82314F97F842Q35758252-4AA87087-5A14-41E4-A182-4E2BE7977E06Q35861466-06501E86-1EF4-4DE1-BED3-E78D598B876FQ36003095-D149C632-19B8-45AC-AA90-C62FA5A80583Q36426091-0D15A9C0-794C-4863-A19B-C3E2A446A15CQ36773098-A34D9C45-33B9-4190-BD70-260A53B16E75Q37375752-6D7AFEFF-DC9A-44C9-9915-05FE0869F939Q37658483-A15B3645-CB8B-41B0-A6A8-984306BB6F29Q37721284-B261438E-31EC-40C7-882A-FF24F748DE84Q37740511-F0290DCE-E2D7-4EB0-993F-03480DD7DAFEQ37928188-A6CD08A2-1C5E-4A93-BA8F-0F9F58FEFDF8Q38164339-439E8EB3-CD9F-4959-8DBD-9F70A60C9313Q38356739-3687CA6F-693D-4108-BA81-2EA054796EDDQ43101728-93D68F77-9D52-4471-A088-97D56049C12DQ49300308-A386272B-FC52-4E89-86AB-D38E8A98681BQ53426999-967708FB-E519-41CE-889C-C02C6BB384FB
P2860
Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Advances in the biology and ge ...... ions for diagnosis and therapy
@ast
Advances in the biology and ge ...... ions for diagnosis and therapy
@en
type
label
Advances in the biology and ge ...... ions for diagnosis and therapy
@ast
Advances in the biology and ge ...... ions for diagnosis and therapy
@en
prefLabel
Advances in the biology and ge ...... ions for diagnosis and therapy
@ast
Advances in the biology and ge ...... ions for diagnosis and therapy
@en
P2093
P2860
P1476
Advances in the biology and ge ...... ions for diagnosis and therapy
@en
P2093
H William Schnaper
Jeffrey B Kopp
Laura Barisoni
P2860
P304
P356
10.1043/1543-2165-133.2.201
P577
2009-02-01T00:00:00Z